Barbro Näsman‐Glaser

513 total citations
18 papers, 409 citations indexed

About

Barbro Näsman‐Glaser is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Barbro Näsman‐Glaser has authored 18 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Barbro Näsman‐Glaser's work include Immunotherapy and Immune Responses (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (3 papers). Barbro Näsman‐Glaser is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (3 papers). Barbro Näsman‐Glaser collaborates with scholars based in Sweden, Iran and France. Barbro Näsman‐Glaser's co-authors include Lotta Hansson, Håkan Mellstedt, Anders Österborg, Marzia Palma, Fariba Mozaffari, Giusy Gentilcore, Susanne Tornhamre, Richard Rosenquist, Leif Stenke and Emma Young and has published in prestigious journals such as Blood, European Journal of Biochemistry and Biochemical Pharmacology.

In The Last Decade

Barbro Näsman‐Glaser

18 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbro Näsman‐Glaser Sweden 12 206 138 117 117 63 18 409
Chiara Cavallini Italy 14 111 0.5× 106 0.8× 176 1.5× 65 0.6× 51 0.8× 20 408
Anna Brandt Germany 9 109 0.5× 243 1.8× 138 1.2× 54 0.5× 62 1.0× 17 470
R G Wickremasinghe United Kingdom 16 72 0.3× 92 0.7× 299 2.6× 109 0.9× 42 0.7× 25 537
Chengxin Luo China 10 89 0.4× 98 0.7× 119 1.0× 44 0.4× 32 0.5× 23 363
Angela Pitisci Italy 13 156 0.8× 73 0.5× 130 1.1× 54 0.5× 23 0.4× 21 538
Nicole Fortenbery United States 8 275 1.3× 109 0.8× 249 2.1× 54 0.5× 34 0.5× 10 577
Emira Bousoik United States 10 94 0.5× 129 0.9× 215 1.8× 30 0.3× 38 0.6× 11 434
Jeff Subleski United States 11 474 2.3× 221 1.6× 167 1.4× 31 0.3× 33 0.5× 15 640
Javier Avila‐Cariño Sweden 14 184 0.9× 131 0.9× 196 1.7× 86 0.7× 96 1.5× 24 494
Sen Zhang China 10 121 0.6× 62 0.4× 140 1.2× 32 0.3× 19 0.3× 33 364

Countries citing papers authored by Barbro Näsman‐Glaser

Since Specialization
Citations

This map shows the geographic impact of Barbro Näsman‐Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbro Näsman‐Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbro Näsman‐Glaser more than expected).

Fields of papers citing papers by Barbro Näsman‐Glaser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbro Näsman‐Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbro Näsman‐Glaser. The network helps show where Barbro Näsman‐Glaser may publish in the future.

Co-authorship network of co-authors of Barbro Näsman‐Glaser

This figure shows the co-authorship network connecting the top 25 collaborators of Barbro Näsman‐Glaser. A scholar is included among the top collaborators of Barbro Näsman‐Glaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbro Näsman‐Glaser. Barbro Näsman‐Glaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Palma, Marzia, Lotta Hansson, Lars Adamson, et al.. (2018). Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients. European Journal Of Haematology. 101(1). 68–77. 13 indexed citations
2.
3.
Palma, Marzia, Giusy Gentilcore, Fariba Mozaffari, et al.. (2016). T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. Haematologica. 102(3). 562–572. 130 indexed citations
4.
Nilsson, Anders, Barbro Näsman‐Glaser, Lena Kanter, et al.. (2016). Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia. Leukemia & lymphoma. 58(8). 1903–1913. 12 indexed citations
5.
6.
Palma, Marzia, Lotta Hansson, Aniruddha Choudhury, et al.. (2011). Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunology Immunotherapy. 61(6). 865–879. 53 indexed citations
7.
Adamson, Lars, Marzia Palma, A Choudhury, et al.. (2009). Generation of a Dendritic Cell‐based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large‐scale Production. Scandinavian Journal of Immunology. 69(6). 529–536. 13 indexed citations
8.
Hansson, Lotta, I. Eriksson, Barbro Näsman‐Glaser, et al.. (2007). Idiotype protein vaccination in combination with adjuvant cytokines in patients with multiple myeloma - evaluation of T-cell responses by different read-out systems. Haematologica. 92(1). 110–114. 10 indexed citations
9.
Hansson, Lotta, et al.. (2007). Long‐term effects of idiotype vaccination on the specific T‐cell response in peripheral blood and bone marrow of multiple myeloma patients. European Journal Of Haematology. 79(5). 371–381. 3 indexed citations
10.
Robinson, N. Edward, et al.. (2004). Assessment of leukotriene B4 production in leukocytes from horses with recurrent airway obstruction. American Journal of Veterinary Research. 65(3). 289–295. 17 indexed citations
11.
12.
Näsman‐Glaser, Barbro, et al.. (2002). Evaluation of leukotriene biosynthetic capacity in lung tissues from horses with recurrent airway obstruction. American Journal of Veterinary Research. 63(6). 794–798. 6 indexed citations
13.
Tornhamre, Susanne, et al.. (2001). Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C4 synthase in human blood cells. Biochemical Pharmacology. 62(7). 903–911. 43 indexed citations
14.
Sjölinder, Mikael, Leif Stenke, Barbro Näsman‐Glaser, et al.. (2000). Aberrant expression of active leukotriene C4 synthase in CD16+ neutrophils from patients with chronic myeloid leukemia. Blood. 95(4). 1456–1464. 20 indexed citations
15.
Tornhamre, Susanne, et al.. (1998). Demonstration of leukotriene‐C4 synthase in platelets and species distribution of the enzyme activity. European Journal of Biochemistry. 251(1-2). 227–235. 23 indexed citations
16.
Lindgren, J A, Leif Stenke, Mahmoud Mansour, et al.. (1993). Formation and effects of leukotrienes and lipoxins in human bone marrow.. PubMed. 6(1-3). 313–20. 36 indexed citations
17.
Stenke, Leif, et al.. (1991). Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia.. PubMed. 21B. 883–6. 14 indexed citations
18.
Edenius, Charlotte, et al.. (1991). Metabolism of Granulocyte-Derived Leukotriene A4 in Human Platelets and Respiratory Tissue: Transcellular Formation of Lipoxins and Leukotrienes. Advances in experimental medicine and biology. 314. 281–288. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Cavallini Breakdown of academic impact, for papers by Anna Brandt Breakdown of academic impact, for papers by R G Wickremasinghe Breakdown of academic impact, for papers by Chengxin Luo Breakdown of academic impact, for papers by Angela Pitisci Breakdown of academic impact, for papers by Nicole Fortenbery Breakdown of academic impact, for papers by Emira Bousoik Breakdown of academic impact, for papers by Jeff Subleski Breakdown of academic impact, for papers by Javier Avila‐Cariño Breakdown of academic impact, for papers by Sen Zhang
Rankless by CCL
2026